Pharming Group N.V.
PHGUF
$0.90
$0.1113.92%
| 06/30/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | -1.22M | -3.12M | 3.46M | 1.32M | |
| Total Depreciation and Amortization | -293.00K | 1.76M | 2.90M | 3.16M | |
| Total Amortization of Deferred Charges | -- | 884.00K | -- | -- | |
| Total Other Non-Cash Items | -2.43M | 13.45M | 1.73M | -15.30M | |
| Change in Net Operating Assets | -9.29M | -1.38M | -4.56M | 1.20M | |
| Cash from Operations | -13.22M | 11.58M | 3.53M | -9.62M | |
| Capital Expenditure | -214.00K | -304.00K | -147.00K | -771.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 36.61M | -3.60M | -58.08M | -66.27M | |
| Cash from Investing | 36.39M | -3.91M | -58.23M | -67.04M | |
| Total Debt Issued | 104.80M | -- | -- | -- | |
| Total Debt Repaid | -135.69M | -1.28M | -1.01M | -1.26M | |
| Issuance of Common Stock | 2.58M | 253.00K | 8.55M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -695.00K | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 7.00K | 6.00K | -2.30M | -676.00K | |
| Cash from Financing | -28.30M | -1.02M | 5.24M | -2.63M | |
| Foreign Exchange rate Adjustments | 381.00K | 439.00K | -913.00K | -467.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -4.75M | 7.09M | -50.37M | -79.76M | |
